NCT06605794View on ClinicalTrials.gov

FreeFlow Percutaneous Atrial Septal Shunt for IPAH

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

September 11, 2027

Study Completion Date

September 11, 2027

Conditions
Pulmonary Arterial Hypertension
Interventions
DEVICE

FreeFlow percutaneous atrial septal shunt

The trial devices included a percutaneous atrial septal shunt and an atrial septal shunt delivery system. The specifications of the atrial septal shunt device were -φ5, φ7, φ9, φ11, and the specifications of the atrial septal shunt delivery system-FFISS-B were 9F and 10F.

Trial Locations (1)

200032

RECRUITING

180 Fenglin Road, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER